United Therapeutics | UTHR - 营业费用



金融业
股票价格
USD 600.56
资产
USD 7.22B
现金及等价物
USD 1.8B
销售成本
USD 99.5M
流动资产
USD 3.48B
流动负债
USD 607.8M
债务
USD 200M
EBIT
USD 375.6M
EBITDA
USD 355M
员工
1.31K
EPS每股收益
USD 7.27
股本和储备
USD 6.4B
销售毛利
USD 683.8M
债务利息支出
USD 2.9M
利息收入
USD 31.5M
贷款资金
USD 100M
市值
USD 28.38B
净收入
USD 333M
营业费用
USD 6.4B
营业利润
USD 330.8M
普通股股本
USD 42.68M
PE价格收益
19.15
税前利润
USD 372.7M
销售收入
USD 783.3M
销售和管理费用
USD 206.7M
股票
USD 193.8M
贸易债权人
USD 497.8M
应收帐款人
USD 310.3M


营业费用 更改 日
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 133.3M 6.04M 2026-06
Baxter International USD 6.5B 3.82B 2026-09
Bayer EUR 10.04B 168M 2026-06
BioCryst Pharmaceuticals USD 119.78M 673.63M 2026-06
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Halozyme Therapeutics USD 193.34M 1.15M 2026-06
Insmed USD 606.26M 79.46M 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
J&J USD 18.93B 1.09B 2026-09
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Moderna USD 960M 817M 2026-06
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 89B 3.81B 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09